For the year ending 2025-12-31, ORKA has $488,617K in assets. $16,687K in debts. $46,935K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 46,935 | |||
| Marketable securities, current | 290,109 | |||
| Prepaid expenses and other current assets | 6,813 | |||
| Total current assets | 343,857 | |||
| Marketable securities, long-term | 142,539 | |||
| Property and equipment, net | 288 | |||
| Operating lease right-of-use assets | 1,830 | |||
| Other non-current assets | 103 | |||
| Total assets | 488,617 | |||
| Accounts payable | 4,155 | |||
| Accrued expenses and other current liabilities | 10,591 | |||
| Operating lease liability, current | 619 | |||
| Related party accounts payable and other current liabilities | 9 | |||
| Total current liabilities | 15,374 | |||
| Operating lease liability, non-current | 1,313 | |||
| Total liabilities | 16,687 | |||
| Series b non-voting convertible preferred stock, 0.001 par value 251,504 shares authorized as of december 31, 2025 and 2024 137,138 shares issued and outstanding as of december 31, 2025 and 2024 | 2,931 | |||
| Common stock, 0.001 par value as of december 31, 2025 and 2024 545,000,000 shares authorized as of december 31, 2025 and 2024, 48,722,309 and 37,440,510 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 49 | |||
| Additional paid-in capital | 657,561 | |||
| Accumulated other comprehensive income (loss) | 546 | |||
| Accumulated deficit | -189,157 | |||
| Total stockholders equity | 471,930 | |||
| Total liabilities and stockholders equity | 488,617 | |||
Oruka Therapeutics, Inc. (ORKA)
Oruka Therapeutics, Inc. (ORKA)